ClinicalTrials.gg
Not yet recruitingNCT07797504Updated Sep 1, 2026

Ready for Recovery Pilot Trial

An interventional study of Ready for Recovery and Enhanced Ready for Recovery in Aortic Aneurysm, sponsored by Massachusetts General Hospital. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a three-arm, randomized pilot trial to examine the feasibility, acceptability, and preliminary efficacy of two multicomponent interventions to promote recovery from aortic aneurysm repair procedures.

Read the detailed description

This is a three-arm, randomized pilot trial to examine the feasibility, acceptability, and preliminary efficacy of two multicomponent programs (Ready for Recovery and an enhanced version of the program) to prepare patients for aortic aneurysm repair and to promote their recovery. Ready for Recovery is a 6-week collaborative care program to prepare individuals for surgical procedures to repair an aortic aneurysm. Participants will speak with a study trainer on the phone each week and will set goals related to physical activity, a healthy diet, and inspiratory muscle training. They also will be given resources to reduce stress, treat anxiety and depression (if present), and stop smoking, and the study team will make recommendations regarding medication adjustments to reduce complications after surgery. The enhanced version has an additional four weeks of phone sessions post-surgery, to provide support and guidance during the early recovery period. The control condition will be standard medical care. The primary outcome is feasibility (measured by proportion of sessions completed). Secondary outcomes include acceptability (measured by weekly 0-10 utility ratings) and preliminary impact on functional, psychological, and health behavior outcomes.

02

Conditions studied

  • Aortic Aneurysm

Browse trials for

03

In context

Aortic Aneurysm

222 studies on the registry are indexed under Aortic Aneurysm; 63 are open to participants now.

This study's planned enrollment of 45 is below the median of 62 across 101 interventional studies indexed under Aortic Aneurysm.

Browse Aortic Aneurysm studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,586 studies on the registry; 447 are open to participants now.

Of its 222 completed or terminated interventional studies of FDA-regulated products, 168 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults undergoing elective aortic aneurysm repair (open or endovascular)

Exclusion criteria

Exclusion Criteria:

  • Emergent aortic aneurysm repair
  • Cognitive disturbance
  • Functional impairment significantly impacting the ability to stand or walk
  • Current pregnancy or plan to become pregnant prior to surgery
  • Inability to write/speak fluently in English
  • Lack of access to a phone, computer, or tablet with internet access
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
45 participants (estimated)

Study arms

  • Experimental
    Ready for Recovery

    Participants in this arm will receive the 6-week Ready for Recovery intervention prior to surgery.

    Behavioral: Ready for Recovery

  • Experimental
    Enhanced Ready for Recovery

    Participants in this arm will receive the 6-week Ready for Recovery intervention prior to surgery, plus an additional 4-week intervention post-surgery.

    Behavioral: Enhanced Ready for Recovery

  • No intervention
    Standard Medical Care

    Participants in this arm will receive standard medical care and no additional interventions.

Interventions

  • BehavioralReady for Recovery

    The Ready for Recovery program is a 6-week, multicomponent, tailored, prehabilitation intervention to promote the optimization of medical and psychological status prior to surgery. Its key components include education, enhancement of beneficial health behaviors, reduction of negative psychological symptoms, and the promotion of social support. Following an initial session, the team will develop a customized prehabilitation plan for each participant. Participants will work towards goals each week and will discuss progress with their study trainer via weekly phone sessions, which will continue until the scheduled surgical procedure.

  • BehavioralEnhanced Ready for Recovery

    The enhanced Ready for Recovery program is a 10-week, multicomponent, tailored, prehabilitation intervention to promote recovery from aortic aneurysm repair. Its key components include education, enhancement of beneficial health behaviors, reduction of negative psychological symptoms, and the promotion of social support. Following an initial session, the team will develop a customized prehabilitation plan for each participant. Participants will work towards goals each week and will discuss progress with their study trainer via weekly phone sessions, which will continue until the scheduled surgical procedure. Following surgery, participants will engage in four additional weekly sessions to discuss the recovery process and plan for longer-term behavior change.

06

What researchers measure

Primary outcomes

  1. Intervention feasibility

    Percentage of intervention phone sessions completed

    Time frame: Weekly over 6 weeks (Ready for Recovery group) or 10 weeks (Enhanced Ready for Recovery group)

Secondary outcomes

  1. Intervention Utility

    Participants will rate the utility of the Ready for Recovery program or enhanced Ready for Recovery program on an 11-point Likert scale (0-10), with 0 being not at all helpful and 10 being very helpful.

    Time frame: 6 weeks (Ready for Recovery) or 10 weeks (Enhanced Ready for Recovery)

  2. Change in functional capacity (1 Minute Sit to Stand Test)

    Functional capacity will be measured using the 1-minute Sit to Stand Test. Participants will be instructed to stand up and sit back down on an armless chair repeatedly for one minute as quickly as possible. The number of times the participant fully stands and then sits down again will be recorded.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

Other outcomes

  1. Change in physical function (PROMIS PF-20)

    Physical function will be measured using the 20-item PROMIS Physical Function Scale (PROMIS PF-20). PROMIS PF-20 scores range from 20 to 100, with higher scores indicating higher levels of physical function.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  2. Change in physical health-related quality of life (Medical Outcomes Study Short Form-12 [SF-12] physical component score)

    The SF-12 physical component score will be used to assess physical health-related quality of life (Range: 0-100). Higher scores indicate higher levels of physical health-related quality of life.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  3. Change in mental health-related quality of life (Medical Outcomes Study Short Form-12 [SF-12] mental component score)

    The SF-12 mental component score will be used to assess mental health-related quality of life (Range: 0-100). Higher scores indicate higher levels of mental health-related quality of life.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), post-operation (1-2 days before or after hospital discharge), 90 days post-discharge

  4. Change in depressive symptoms (9-item Patient Health Questionnaire [PHQ-9])

    Depressive symptoms will be measured using the 9-item Patient Health Questionnaire (PHQ-9). The PHQ-9 ranges from 0-27, with higher scores indicating higher levels of depression.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  5. Change in anxiety symptoms (7-item Generalized Anxiety Disorder Scale [GAD-7])

    Anxiety will be measured using the 7-item Generalized Anxiety Disorder scale (GAD-7). The GAD-7 ranges from 0-21, with higher scores indicating higher levels of anxiety

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  6. Change in perceived stress (Perceived Stress Scale)

    Perceived stress will be assessed via the Perceived Stress Scale (PSS). PSS scores range from 0-40, with higher scores indicating higher levels of perceived stress.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  7. Change in cognition (telephonic Montreal Cognitive Assessment [t-MoCA])

    Cognition will be measured using the telphonic Montreal Cognitive Assessment (t-MoCA). t-MoCA scores range from 0 to 22, with higher scores indicating better cognition.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  8. Change in perceived social support (Multidimensional Scale of Perceived Social Support)

    Perceived social support will be measured by the Multidimensional Scale of Perceived Social Support (MSPSS). MSPSS scores range from 1-7, with higher scores indicating higher levels of perceived social support.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  9. Change in self-reported physical activity (International Physical Activity Questionnaire [IPAQ]; in metabolic equivalent-minutes/week)

    This will be measured via the International Physical Activity Questionnaire (IPAQ) as a secondary measure of physical activity.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  10. Changes in cigarette smoking (in number of cigarettes smoked per week)

    Participants will be asked how many cigarettes they have smoked in the past week.

    Time frame: Baseline, post-intervention (1-5 days prior to surgery), 30 days post-discharge, 90 days post-discharge

  11. Incidence of postoperative complications

    We will review participant records to identify cardiac, pulmonary, renal, and cognitive complications that occur during the post-operative hospital stay.

    Time frame: Perioperative/periprocedural

  12. Delirium incidence

    Delirium incidence will be assessed through review of the electronic health record using a validated tool designed for this purpose. It will be identified through a diagnosis of delirium, use of medications (e.g., antipsychotic medications) for the management of agitation, or mentions of confusion, disorientation, or agitation in nursing notes.

    Time frame: Perioperative/periprocedural

  13. Intensive Care Unit (ICU) length of stay

    We will measure the amount of time the participant spends in the ICU following the surgical procedure.

    Time frame: Perioperative/periprocedural

  14. Hospital length of stay

    We will measure the amount of time the participant spends hospitalized for aortic aneurysm repair.

    Time frame: Perioperative/periprocedural

  15. Incidence of hospital readmissions

    We will measure the incidence and time of hospital readmissions following discharge after the surgical procedure.

    Time frame: 30 days post-discharge, 90 days post-discharge

  16. Mortality

    We will measure the incidence and timing of mortality, based on electronic health record review.

    Time frame: 30 days post-discharge, 90 days post-discharge.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07797504
Responsible party
Christopher Celano (Associate Director, Cardiac Psychiatry Research Program, Massachusetts General Hospital) — Principal investigator
First posted
Sep 1, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Aug 31, 2027 (estimated)
Completion
Nov 30, 2027 (estimated)
Last update
Sep 1, 2026

Study contacts

Christopher M Celano, M.D.
Contact
ccelano@mgh.harvard.edu
617-726-6485
Christopher M Celano, M.D.
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion